Virbac

Virbac is one of the world’s largest independent animal health companies. It develops, manufactures, and markets a comprehensive portfolio of vaccines, pharmaceuticals, parasiticides, dermatology products, dental care items, nutritional supplements and diagnostic tools for both companion animals and livestock. The company has recently expanded into novel modalities such as therapeutic antibodies through partnerships like MabGenesis. Its commercial footprint spans over100 countries with strong R&D capabilities across five continents. In recent years it has launched innovative solutions including an antimicrobial-free treatment for canine otitis externa in Asia and URSOLYX™ Soft Chews targeting skeletal muscle mRNA expression in dogs via collaboration with Emmyon Inc.